![]() In Mexico, the cases have reached 2,519,269, with 233,047 deaths. The cases are also increasing in Mexico and Canada. ![]() North America has been witnessing a growing number of COVID-19 cases since its outbreak.For instance, according to Worldometer, the number of cases increased to 34,540,845, with 620,249 deaths reported in the US as of July 1st, 2021. The global impacts of COVID-19 are being felt across several markets.Although the healthcare sector had witnessed SARS, H1N1, and other outbreaks in the last few years, the severity of the COVID-19 has made the situation more complicated due to its mode of transmission. The fear of COVID-19 has hit the business across the world.COVID-19 virus outbreak was first observed in December 2019 in Wuhan (China), and it has spread to ~100 countries across the world, with the World Health Organization (WHO) stating it as a public health emergency. Therapeutic intervention included use of the FlowAid FA-100 SCCD set to the arterial setting.The SCCD is a self-contained device that stimulates contraction of the calf muscles via application of four electrodes to the posterior of the leg.Īlso, a research study published in 2016 by medical research, Sequential contraction compression device (SCCD) therapy addresses many of the compliance issues of IPC use. SCCD works by stimulating calf muscle contraction through a series of timed, coordinated electrical pulses to the neuromuscular junction.This generates a sequential, peristaltic series of contractions from distal to proximal, stimulating enhanced blood flow in both venous return and arterial inflow. Additionally, occurrence of lymphatic and venous disorders is among the other factors expected to fuel the demand for home sequential compression devices system in North America.īased on device type, the simultaneous sequential compression device segment led the North America home sequential compression devices system market in 2021.Simultaneous sequential compression device (SSCD) that can compress both limbs simultaneously and sequentially. For instance, the UnitedHealthcare Medicare, one of the leading insurance providers in the US, offers coverage for the at-home use of pneumatic compression devices to treat lymphedema. ![]() The awareness about health insurance coverage for venous insufficiency treatments by different health insurance schemes further fuels the home sequential compression devices market growth. Moreover, owing to the ongoing COVID-19 pandemic, patients prefer taking medical treatments at home to avoid the risk of COVID-19 infection. ![]() These sleeves consist of built-in chambers that fill with air and then deflate sequentially to push fluids toward desired directions.Thus, these devices are simple to use healthcare providers educate the patients about the use of home sequential compression devices. The sequential compression pumps are widely used in hospitals, clinics, and home care settings.Patients need to place their affected legs in unique sleeves connected to a portable pump. Venous insufficiency disorders can be treated by procedures such as compression stockings and wraps, venopneumatic compression pumps, minimally invasive venous ablation, and radiofrequency ablation.Sequential compression devices operate through automatic and sequential expansion and collapse to drive fluids back into the veins as well as to push these fluids back to heart from the lower parts of the body. The home sequential compression devices market in North America is expected to grow from US$ 428.66 million in 2021 to US$ 691.88 million by 2028 it is estimated to grow at a CAGR of 7.1% from 2021 to 2028.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |